Many specialists ignore the requirements in the schedule of benefits and expect family doctors to deal with follow-up care, ordering tests and admin work, argues Dr. Adam Stewart.
The community pharmacist is well poised to recognize the patient population who would benefit most from COVID-19 antivirals, is able to employ strategies to address DDIs related to this therapy and contribute to improved patient outcomes using their unique knowledge and skills.